Skip to main navigation Skip to search Skip to main content

Cell type-specific enhancers regulate IL-22 expression in innate and adaptive type 3 lymphoid cells

  • Ankita Saini
  • , Leone S. Hopkins
  • , Vanida A. Serna
  • , Matthew V.D. McCullen
  • , Nicholas G. Selner
  • , Bishan Bhattarai
  • , José L. Fachi
  • , Rebecca A. Glynn
  • , Katharina E. Hayer
  • , Craig H. Bassing
  • , Marco Colonna
  • , Eugene M. Oltz

Research output: Contribution to journalArticlepeer-review

Abstract

IL-22, a signature cytokine for type 3 lymphoid cells, including T helper 17/22 (Th17/22) and type 3 innate lymphoid cells (ILC3), mediates epithelial homeostasis and protective pathogen responses in barrier tissues. Upon dysregulation, IL-22 can drive chronic inflammatory diseases, yet little is known about transcriptional elements modulating its expression. Here, we identify two enhancers, E22-1 and E22-2, with distinct capacities for regulating Il22 expression in type 3 lymphoid cells. Both enhancers are necessary for protection from Citrobacter rodentium infection and for the onset of IL-22-mediated psoriasis. E22-2 is specifically required for IL-22 expression in ILC3s, while E22-1 functions in both Th17/22 and ILC3. The ILC3 specificity of E22-2 is attributed to the presence of multiple Runx3 sites and the lack of a functional RORγt motif. We conclude that Th17/22 and ILC3 cells use distinct cis-elements to differentially regulate IL-22 expression, while orchestrating homeostatic protection and pathogen defense in barrier tissues.

Original languageEnglish
Article number3960
JournalNature Communications
Volume17
Issue number1
DOIs
StatePublished - Dec 2026

Fingerprint

Dive into the research topics of 'Cell type-specific enhancers regulate IL-22 expression in innate and adaptive type 3 lymphoid cells'. Together they form a unique fingerprint.

Cite this